Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Can Intranasal Ketorolac Tromethamine Prescribed Postoperatively After Major Female Pelvic Reconstructive Surgery Reduce Consumption of Prescribed Narcotics?

Next Previous
Trial Profile

Can Intranasal Ketorolac Tromethamine Prescribed Postoperatively After Major Female Pelvic Reconstructive Surgery Reduce Consumption of Prescribed Narcotics?

Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ketorolac (Primary) ; Hydrocodone/paracetamol; Ibuprofen; Oxycodone; Paracetamol
  • Indications Postoperative pain
  • Focus Therapeutic Use

Most Recent Events

  • 27 Jul 2022 Planned initiation date changed from 1 Oct 2021 to 1 Jan 2021.
  • 27 Jul 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
  • 25 Jun 2021 Planned End Date changed from 30 Jun 2021 to 1 Oct 2022.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top